# Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

> **NCT01881334** · — · AVAILABLE · sponsor: **Joanne Kurtzberg, MD**

## Conditions studied

- Hematologic Malignancies
- Inborn Errors of Metabolism Disorders
- Immune Deficiencies

## Interventions

- **BIOLOGICAL:** CliniMACS CD34 Reagent System

## Key facts

- **NCT ID:** NCT01881334
- **Lead sponsor:** Joanne Kurtzberg, MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01881334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01881334, "Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT01881334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*